4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.

Healthcare Biotechnology Taiwan OTC Exchange
6.72 TWD
Close of Nov 6, 2026
6.47 13.75
Market cap
TWD 605M
P/E
39.5x
P/B
2.37x
ROE
9.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 4186.TWO undervalued?

Graham number
Price6.72
Graham value3.29
Premium104.1%

4186.TWO trades 104.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Taiwan Advance Bio-Pharmaceutical Inc. fundamental analysis

No fundamental analysis for Taiwan Advance Bio-Pharmaceutical Inc. yet.

Taiwan Advance Bio-Pharmaceutical Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA and rapid test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers stem cell banking services for newborn and ad…

Full company profile